Progression-free Survival and Safety at 3.5 Years of Follow-Up: Results from the Randomized Phase 3 PRIMA/ENGOT-OV26/GOG-3012 Trial of Niraparib Maintenance Treatment in Patients with Newly Diagnosed Ovarian Cancer – a Plain Language Summary
Future oncology (London, England)(2024)
关键词
Platinum-Sensitive Ovarian Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要